Skip to content

The effect of intravenous vitamin C on the serum level of phosphorus in hemodialysis patients

Effect of intravenous vitamin C on the serum phosphorus level in hemodialysis patients compared to control group

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201406118032N3
Enrollment
60
Registered
2014-09-29
Start date
2014-09-01
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

End stage renal disease. Chronic kidney disease, stage 5

Interventions

Intervention 1: Intervention group will receive 500 mg of vitamin C intravenously three times a week after every dialysis session for 8 weeks. Intervention 2: Control group will receive 5 cc normal s
Treatment - Drugs
Placebo
Intervention group will receive 500 mg of vitamin C intravenously three times a week after every dialysis session for 8 weeks.
Control group will receive 5 cc normal saline intravenously 3 times a week after every dialysis session for 8 weeks.

Sponsors

Research Deputy of Tabriz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: inclusion criteria: at least 6 months hemodialysis history; serum phosphor level higher than 5.5. exclusion criteria: history of liver failure; heart failure; respiratory failure and history of vitamin c intake.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Serum level of phosphor. Timepoint: Baseline and 2 months after. Method of measurement: paraclinical.;Serum calcium level. Timepoint: Baseline and 2 months after. Method of measurement: paraclinical.;Blood Hemoglobin level. Timepoint: Baseline and 2 months after. Method of measurement: paraclinical.;Serum PTH. Timepoint: Baseline and 2 months after. Method of measurement: paraclinical.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Jalal Etemadi

Tabriz University of Medical Sciences

drjalal_etemadi@yahoo.com+98 41 1668 6153

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026